ID: ALA2385364

Max Phase: Preclinical

Molecular Formula: C22H30N2O

Molecular Weight: 338.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1CN(C(c2ccccc2)c2ccccc2)[C@H](CCCCO)CN1

Standard InChI:  InChI=1S/C22H30N2O/c1-18-17-24(21(16-23-18)14-8-9-15-25)22(19-10-4-2-5-11-19)20-12-6-3-7-13-20/h2-7,10-13,18,21-23,25H,8-9,14-17H2,1H3/t18-,21-/m1/s1

Standard InChI Key:  SDCQKHHLVSVTHT-WIYYLYMNSA-N

Associated Targets(non-human)

Voltage-gated L-type calcium channel alpha-1C subunit 1321 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Voltage-gated N-type calcium channel alpha-1B subunit 471 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 338.50Molecular Weight (Monoisotopic): 338.2358AlogP: 3.60#Rotatable Bonds: 7
Polar Surface Area: 35.50Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.65CX LogP: 3.97CX LogD: 1.75
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.76Np Likeness Score: 0.24

References

1. Borzenko A, Pajouhesh H, Morrison JL, Tringham E, Snutch TP, Schafer LL..  (2013)  Modular, efficient synthesis of asymmetrically substituted piperazine scaffolds as potent calcium channel blockers.,  23  (11): [PMID:23639535] [10.1016/j.bmcl.2013.03.114]

Source